Life Technologies

Life Technologies Parkinson’s disease cell models

Issue link: http://life-technologies.uberflip.com/i/215145

Contents of this Issue

Navigation

Page 13 of 28

Cytogenetic analysis Over time, chromosomal mutations in iPSCs can be detrimental to the health and potential capability of the cells. Monitoring the stability of the chromosomes is important to confirm that the iPSCs are still free of chromosomal aberrations. For each iPSC line, cytogenetic analysis was performed on 20 G-banded metaphase cells derived from the expanded clones. The results showed that all tested clones from all 6 lines displayed the normal karyotype, confirming no chromosomal abnormalities. Representative results are shown in Figure 3. A BC Figure 3. Cytogenetic analysis of iPSCs from PD-2 (A) and PD-3 (B) donors or control individual Ctrl-2 (C). iPSC clones (passage 14 (A), passage 11 (B), and passage 12 (C)) were cultured in iPSC medium supplemented with KnockOut™ Serum Replacement (KSR) on 6-well MEF plates for 4 days. Cells were harvested for karyotype analysis. All clones tested demonstrated a normal karyotype. No clonal abnormality was detected at the G-band level of resolution. 14 Life Technologies | Parkinson's cell model CULTURE ENGINEERING DIFFERENTIATION CHARACTERIZATION

Articles in this issue

Links on this page

view archives of Life Technologies - Life Technologies Parkinson’s disease cell models